Tim Senior's Top Recommendations

These recommendations were last updated 42 minutes ago.

	Sociability and susceptibility to the common cold. [My Copy] Psychological science : a journal of the American Psychological Society / APS, Vol. 14, No. 5. (September 2003), pp. 389-395. by S. Cohen, W. J. Doyle, R. Turner, C. M. Alper, D. P. Skoner posted by 1 person cbforrest
	Social support as coping assistance. [My Copy] Journal of consulting and clinical psychology, Vol. 54, No. 4. (August 1986), pp. 416-423. by P. A. Thoits posted by 1 person cbforrest
	Social support and the perception of geographical slant [My Copy] Journal of Experimental Social Psychology, Vol. 44, No. 5. (September 2008), pp. 1246-1255. by S. Schnall, K. Harber, J. Stefanucci, D. Proffitt posted by 1 person cbforrest
	Lack of social support and incidence of coronary heart disease in middle-aged Swedish men [My Copy] Psychosom Med, Vol. 55, No. 1. (1 January 1993), pp. 37-43. by K. Orth-Gomer, A. Rosengren, L. Wilhelmsen posted by 1 person cbforrest
	Social Networks, Social Support, and Survival After Breast Cancer Diagnosis [My Copy] J Clin Oncol, Vol. 24, No. 7. (1 March 2006), pp. 1105-1111. by Candyce H. Kroenke, Laura D. Kubzansky, Eva S. Schernhammer, Michelle D. Holmes, Ichiro Kawachi posted by 1 person cbforrest
	Recursive Processes in Self-Affirmation: Intervening to Close the Minority Achievement Gap [My Copy] Science, Vol. 324, No. 5925. (17 April 2009), pp. 400-403. by Geoffrey L. Cohen, Julio Garcia, Valerie Purdie-Vaughns, Nancy Apfel, Patricia Brzustoski posted by 2 people cannonsr cbforrest
	Effect of social networks on 10 year survival in very old Australians: the Australian longitudinal study of aging [My Copy] Journal of Epidemiology and Community Health, Vol. 59, No. 7. (1 July 2005), pp. 574-579. by Lynne C. Giles, Gary F. V. Glonek, Mary A. Luszcz, Gary R. Andrews posted by 4 people kdemauro cbforrest camin maciesmom
	Evidence for Cardiomyocyte Renewal in Humans [My Copy] Science, Vol. 324, No. 5923. (3 April 2009), pp. 98-102. by Olaf Bergmann, Ratan D. Bhardwaj, Samuel Bernard, et al.Sofia Zdunek, Fanie Barnabe-Heider, Stuart Walsh, Joel Zupicich, Kanar Alkass, Bruce A. Buchholz, Henrik Druid, Stefan Jovinge, Jonas Frisen posted by 5 people cbforrest brocktice jbhiatt absterga albertlu
	Decomposing health: tolerance and resistance to parasites in animals [My Copy] Philosophical Transactions of the Royal Society B: Biological Sciences, Vol. 364, No. 1513. (12 January 2009), pp. 37-49. by Lars Råberg, Andrea L. Graham, Andrew F. Read posted by 2 people cbforrest pateld5cardiff
	Self-Medication as Adaptive Plasticity: Increased Ingestion of Plant Toxins by Parasitized Caterpillars [My Copy] PLoS ONE, Vol. 4, No. 3. (10 March 2009), e4796. by Michael S. Singer, Kevi C. Mace, Elizabeth A. Bernays posted by 2 people fungal cbforrest
	Effects of social integration on preserving memory function in a nationally representative US elderly population. [My Copy] American journal of public health, Vol. 98, No. 7. (July 2008), pp. 1215-1220. by K. A. Ertel, M. M. Glymour, L. F. Berkman posted by 1 person cbforrest
	Features predicting the success of computerized decision support for prescribing: a systematic review of randomized controlled trials [My Copy] BMC Medical Informatics and Decision Making, Vol. 9, No. 1. (11 February 2009), 11. by Brent Mollon, Jaron Chong, Anne Holbrook, Melani Sung, Lehana Thabane, Gary Foster posted by 3 people schardt patrikgh cbforrest
	Fundamental concepts in genetics: Genetics and the understanding of selection [My Copy] Nature Reviews Genetics, Vol. 10, No. 2. (01 February 2009), pp. 83-93. by Laurence D. Hurst posted by 20 people loriosa psique cbforrest raiyar jmeppley jbhiatt ilyashl ramiro2k bcondon R.E.A.D Zephyrus LabDros gwallau xingxu gjuggler misonneh lp2 druvus pkonings nuin
	Autopoiesis with or without cognition: defining life at its edge [My Copy] Journal of The Royal Society Interface, Vol. 1, No. 1. (22 November 2004), pp. 99-107. by M. Bitbol, Luigi P. Luisi posted by 8 people cbforrest aphilosof zpinhead mattjb tomhebbron ComplexAdaptiveSystems DSTO-CAS rrbarb
	Depression, heart rate variability, and acute myocardial infarction. [My Copy] Circulation, Vol. 104, No. 17. (23 October 2001), pp. 2024-2028. by R. M. Carney, J. A. Blumenthal, P. K. Stein, et al.L. Watkins, D. Catellier, L. F. Berkman, S. M. Czajkowski, C. O'Connor, P. H. Stone, K. E. Freedland posted by 3 people cbforrest lydiapoole sigir
	Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism [My Copy] Apoptosis, Vol. 12, No. 9. (September 2007), pp. 1579-1588. by Zhang, Kun-Ru, Liu, et al. Hai-Tao, Zhang, Hai-Feng, Zhang, Quan-Jiang, Li, Qiu-Xia, Yu, Qiu-Jun, Guo, Wen-Yi, Wang, Hai-Chang, Gao, Feng posted by 1 person cbforrest
	Robustness and Evolvability in Living Systems: (Princeton Studies in Complexity) [My Copy] (15 June 2007) by Andreas Wagner posted by 4 people cbforrest mattjb ComplexAdaptiveSystems DSTO-CAS
	The human disease network. [My Copy] Proceedings of the National Academy of Sciences of the United States of America, Vol. 104, No. 21. (22 May 2007), pp. 8685-8690. by Kwang-Il I. Goh, Michael E. Cusick, David Valle, Barton Childs, Marc Vidal, Albert-László L. Barabási posted by 51 people icecrown frohike robfsouza bertelsen smichan biomcgary pawelsobko CurAbility Scis0000002 qluo cbforrest Network Analysis of Genes Regulated in Renal Diseases daforerog nedwards Dulcinea saket kaarsinogen roys Yanno guhjy aalibes cannin kuhn jfr yas balicea neveaire bundschu raiyar grahamc joepickrell leSyl henning dejori xingxu winterschlaefer naegele Biostatistics Computational-Genomics Bioinformatics Neuroscience steinmetzlab shoshin ic4 generif_paper shikin nolodie GomezLab mingzhi carlk yaredo
	A MITOCHONDRIAL PARADIGM OF METABOLIC AND DEGENERATIVE DISEASES, AGING, AND CANCER: A Dawn for Evolutionary Medicine [My Copy] Annual Review of Genetics, Vol. 39, No. 1. (2005), pp. 359-407. by Douglas C. Wallace posted by 4 people smichan cbforrest raiyar steinmetzlab
	Parentchild relationships and health problems in adulthood in three UK national birth cohort studies [My Copy] European Journal of Public Health, Vol. 15, No. 6. (December 2005), pp. 640-646. by Sarah L. Stewart-Brown, Lynn Fletcher, Michael E. Wadsworth posted by 1 person cbforrest
	Overview of caloric restriction and ageing. [My Copy] Mech Ageing Dev, Vol. 126, No. 9. (September 2005), pp. 913-922. by E. J. Masoro posted by 2 people cbforrest imouthesmp
	Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. [My Copy] The New England journal of medicine, Vol. 347, No. 20. (14 November 2002), pp. 1557-1565. by Paul M. Ridker, Nader Rifai, Lynda Rose, Julie E. Buring, Nancy R. Cook posted by 1 person nm61591
	C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. [My Copy] The New England journal of medicine, Vol. 342, No. 12. (23 March 2000), pp. 836-843. by P. M. Ridker, C. H. Hennekens, J. E. Buring, N. Rifai posted by 1 person nm61591
	Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. [My Copy] The New England journal of medicine, Vol. 336, No. 14. (3 April 1997), pp. 973-979. by P. M. Ridker, M. Cushman, M. J. Stampfer, R. P. Tracy, C. H. Hennekens posted by 1 person nm61591
	Inflammatory markers and risk of developing type 2 diabetes in women. [My Copy] Diabetes, Vol. 53, No. 3. (March 2004), pp. 693-700. by Frank B. Hu, James B. Meigs, Tricia Y. Li, Nader Rifai, JoAnn E. Manson posted by 1 person nm61591
	Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. [My Copy] Diabetes, Vol. 51, No. 4. (April 2002), pp. 1131-1137. by Andreas Festa, Ralph D'Agostino, Russell P. Tracy, Steven M. Haffner, Insulin Resistance Atherosclerosis Study posted by 1 person nm61591
	The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. [My Copy] Diabetes, Vol. 50, No. 10. (October 2001), pp. 2384-2389. by J. I. Barzilay, L. Abraham, S. R. Heckbert, et al.M. Cushman, L. H. Kuller, H. E. Resnick, R. P. Tracy posted by 1 person nm61591
	Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. [My Copy] Journal of molecular medicine (Berlin, Germany), Vol. 81, No. 8. (August 2003), pp. 455-470. by Marc Y. Donath, Joachim Størling, Kathrin Maedler, Thomas Mandrup-Poulsen posted by 1 person nm61591
	Is type II diabetes mellitus a disease of the innate immune system? [My Copy] Diabetologia, Vol. 41, No. 10. (October 1998), pp. 1241-1248. by J. C. Pickup, M. A. Crook posted by 1 person nm61591
	Inflammation as a cardiovascular risk factor. [My Copy] Circulation, Vol. 109, No. 21 Suppl 1. (1 June 2004) by James T. Willerson, Paul M. Ridker posted by 1 person nm61591
	Insulin as an anti-inflammatory and antiatherogenic modulator. [My Copy] Journal of the American College of Cardiology, Vol. 53, No. 5 Suppl. (3 February 2009) by Paresh Dandona, Ajay Chaudhuri, Husam Ghanim, Priya Mohanty posted by 1 person nm61591
	Proinflammatory effects of glucose and anti-inflammatory effect of insulin: relevance to cardiovascular disease. [My Copy] The American journal of cardiology, Vol. 99, No. 4A. (19 February 2007) by Paresh Dandona, Ajay Chaudhuri, Husam Ghanim, Priya Mohanty posted by 1 person nm61591
	Correlation between cardiovascular disease and diabetes mellitus: current concepts. [My Copy] The American journal of medicine, Vol. 116 Suppl 5A (8 March 2004) by Richard W. Nesto posted by 1 person nm61591
	Independent anti-inflammatory effect of insulin in newly diagnosed type 2 diabetes. [My Copy] Diabetes/metabolism research and reviews, Vol. 25, No. 5. (July 2009), pp. 435-441. by Xiao-Ming M. Mao, Hao Liu, Xiao-Jun J. Tao, Guo-Ping P. Yin, Qian Li, Shu-Kui K. Wang posted by 1 person nm61591
	The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. [My Copy] Archives of internal medicine, Vol. 157, No. 21. (24 November 1997), pp. 2413-2446. posted by 1 person nm61591
	Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. [My Copy] BMJ (Clinical research ed.), Vol. 321, No. 7258. (12 August 2000), pp. 412-419. by A. I. Adler, I. M. Stratton, H. A. Neil, et al.J. S. Yudkin, D. R. Matthews, C. A. Cull, A. D. Wright, R. C. Turner, R. R. Holman posted by 1 person nm61591
	C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. [My Copy] Diabetes, Vol. 51, No. 5. (May 2002), pp. 1596-1600. by Dilys J. Freeman, John Norrie, Muriel J. Caslake, et al.Allan Gaw, Ian Ford, Gordon D. Lowe, Denis St S. O'Reilly, Chris J. Packard, Naveed Sattar, West of Scotland Coronary Prevention Study posted by 2 people nm61591 booker
	Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. [My Copy] Journal of the American College of Cardiology, Vol. 53, No. 3. (20 January 2009), pp. 298-304. by Jay S. Skyler, Richard Bergenstal, Robert O. Bonow, et al.John Buse, Prakash Deedwania, Edwin A. Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter Reaven, Robert S. Sherwin, American Diabetes Association, American College of Cardiology Foundation, American Heart Association posted by 4 people ggrassi booker nm61591 guhjy
	Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. [My Copy] Circulation, Vol. 119, No. 2. (20 January 2009), pp. 351-357. by Jay S. Skyler, Richard Bergenstal, Robert O. Bonow, et al.John Buse, Prakash Deedwania, Edwin A. Gale, Barbara V. Howard, M. Sue Kirkman, Mikhail Kosiborod, Peter Reaven, Robert S. Sherwin, American Diabetes Association, American College of Cardiology Foundation, American Heart Association posted by 3 people guhjy booker nm61591
	Glucose control and vascular complications in veterans with type 2 diabetes. [My Copy] The New England journal of medicine, Vol. 360, No. 2. (8 January 2009), pp. 129-139. by William Duckworth, Carlos Abraira, Thomas Moritz, et al.Domenic Reda, Nicholas Emanuele, Peter D. Reaven, Franklin J. Zieve, Jennifer Marks, Stephen N. Davis, Rodney Hayward, Stuart R. Warren, Steven Goldman, Madeline McCarren, Mary Ellen E. Vitek, William G. Henderson, Grant D. Huang, VADT Investigators posted by 10 people ggrassi booker familydoc guhjy omalbam hmoffet Anesthesia and Acute Pain richardh nm61591 djmonstermo
	Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. [My Copy] Lancet, Vol. 366, No. 9500. (26 November 2005), pp. 1849-1861. by A. Keech, R. J. Simes, P. Barter, et al.J. Best, R. Scott, M. R. Taskinen, P. Forder, A. Pillai, T. Davis, P. Glasziou, P. Drury, Y. A. Kesäniemi, D. Sullivan, D. Hunt, P. Colman, M. d'Emden, M. Whiting, C. Ehnholm, M. Laakso, FIELD study investigators posted by 2 people guhjy nm61591
	Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. [My Copy] Circulation, Vol. 102, No. 1. (4 July 2000), pp. 21-27. posted by 1 person nm61591
	Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. [My Copy] The New England journal of medicine, Vol. 341, No. 6. (5 August 1999), pp. 410-418. by H. B. Rubins, S. J. Robins, D. Collins, et al.C. L. Fye, J. W. Anderson, M. B. Elam, F. H. Faas, E. Linares, E. J. Schaefer, G. Schectman, T. J. Wilt, J. Wittes posted by 1 person nm61591
	Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. [My Copy] Lancet, Vol. 357, No. 9260. (24 March 2001), pp. 905-910. posted by 1 person nm61591
	Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. [My Copy] The New England journal of medicine, Vol. 317, No. 20. (12 November 1987), pp. 1237-1245. by M. H. Frick, O. Elo, K. Haapa, et al.O. P. Heinonen, P. Heinsalmi, P. Helo, J. K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen posted by 1 person nm61591
	Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. [My Copy] Archives of internal medicine, Vol. 159, No. 22. (7 1999), pp. 2661-2667. by S. M. Haffner, C. M. Alexander, T. J. Cook, et al.S. J. Boccuzzi, T. A. Musliner, T. R. Pedersen, J. Kjekshus, K. Pyörälä posted by 1 person nm61591
	Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. [My Copy] Lancet, Vol. 366, No. 9493. (8 October 2005), pp. 1267-1278. by C. Baigent, A. Keech, P. M. Kearney, et al.L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes, Cholesterol Treatment Trialists' (CTT) Collaborators posted by 2 people ggrassi nm61591
	Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. [My Copy] Annals of internal medicine, Vol. 140, No. 8. (20 April 2004), pp. 650-658. by S. Vijan, R. A. Hayward, posted by 1 person nm61591
	Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. [My Copy] Lancet, Vol. 364, No. 9435. (7 2004), pp. 685-696. by H. M. Colhoun, D. J. Betteridge, P. N. Durrington, et al.G. A. Hitman, H. A. Neil, S. J. Livingstone, M. J. Thomason, M. I. Mackness, V. Charlton-Menys, J. H. Fuller, posted by 1 person nm61591
	Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). [My Copy] Diabetes care, Vol. 28, No. 5. (May 2005), pp. 1151-1157. by P. S. Sever, N. R. Poulter, B. Dahlöf, et al.H. Wedel, R. Collins, G. Beevers, M. Caulfield, S. E. Kjeldsen, A. Kristinsson, G. T. McInnes, J. Mehlsen, M. Nieminen, E. O'Brien, J. Ostergren posted by 1 person nm61591
	Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. [My Copy] JAMA : the journal of the American Medical Association, Vol. 279, No. 20. (27 May 1998), pp. 1615-1622. by J. R. Downs, M. Clearfield, S. Weis, et al.E. Whitney, D. R. Shapiro, P. A. Beere, A. Langendorfer, E. A. Stein, W. Kruyer, A. M. Gotto posted by 1 person nm61591
	Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). [My Copy] Circulation, Vol. 97, No. 15. (21 April 1998), pp. 1440-1445. posted by 1 person nm61591
	Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. [My Copy] Lancet, Vol. 360, No. 9346. (23 November 2002), pp. 1623-1630. by J. Shepherd, G. J. Blauw, M. B. Murphy, et al.E. L. Bollen, B. M. Buckley, S. M. Cobbe, I. Ford, A. Gaw, M. Hyland, J. W. Jukema, A. M. Kamper, P. W. Macfarlane, A. E. Meinders, J. Norrie, C. J. Packard, I. J. Perry, D. J. Stott, B. J. Sweeney, C. Twomey, R. G. Westendorp, posted by 1 person nm61591
	Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. [My Copy] JAMA : the journal of the American Medical Association, Vol. 287, No. 24. (26 June 2002), pp. 3215-3222. by P. W. Serruys, P. de Feyter, C. Macaya, et al.N. Kokott, J. Puel, M. Vrolix, A. Branzi, M. C. Bertolami, G. Jackson, B. Strauss, B. Meier, posted by 1 person nm61591
	Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. [My Copy] Diabetes, Vol. 48, No. 6. (June 1999), pp. 1289-1294. by B. J. Hoogwerf, A. Waness, M. Cressman, et al.J. Canner, L. Campeau, M. Domanski, N. Geller, A. Herd, A. Hickey, D. B. Hunninghake, G. L. Knatterud, C. White posted by 1 person nm61591
	Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. [My Copy] The New England journal of medicine, Vol. 339, No. 19. (5 November 1998), pp. 1349-1357. posted by 1 person nm61591
	Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. [My Copy] Circulation, Vol. 98, No. 23. (8 December 1998), pp. 2513-2519. by R. B. Goldberg, M. J. Mellies, F. M. Sacks, et al.L. A. Moyé, B. V. Howard, W. J. Howard, B. R. Davis, T. G. Cole, M. A. Pfeffer, E. Braunwald posted by 1 person nm61591
	Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [My Copy] Lancet, Vol. 344, No. 8934. (19 November 1994), pp. 1383-1389. posted by 2 people aleeva nm61591
	The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. [My Copy] JAMA : the journal of the American Medical Association, Vol. 251, No. 3. (20 January 1984), pp. 351-364. posted by 1 person nm61591
	Diabetes and coronary risk equivalency: what does it mean? [My Copy] Diabetes care, Vol. 29, No. 2. (February 2006), pp. 457-460. by S. M. Grundy posted by 1 person nm61591
	Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. [My Copy] Archives of internal medicine, Vol. 157, No. 2. (27 January 1997), pp. 181-188. by C. Abraira, J. Colwell, F. Nuttall, et al.C. T. Sawin, W. Henderson, J. P. Comstock, N. V. Emanuele, S. R. Levin, I. Pacold, H. S. Lee posted by 1 person nm61591
	Exogenous Insulin Administration and Cardiovascular Risk in Non-Insulin-dependent and Insulin-dependent Diabetes Mellitus [My Copy] Annals of Internal Medicine, Vol. 124, No. 1 Part 2. (1 January 1996), pp. 104-109. by Saul Genuth posted by 2 people ggrassi nm61591
	Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. [My Copy] Journal of the American College of Cardiology, Vol. 26, No. 1. (July 1995), pp. 57-65. by K. Malmberg, L. Rydén, S. Efendic, et al.J. Herlitz, P. Nicol, A. Waldenström, H. Wedel, L. Welin posted by 2 people booker nm61591
	Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. [My Copy] Annals of internal medicine, Vol. 141, No. 6. (21 September 2004), pp. 413-420. by K. T. Khaw, N. Wareham, S. Bingham, R. Luben, A. Welch, N. Day posted by 2 people booker nm61591
	The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease. [My Copy] Endocrine reviews, Vol. 19, No. 5. (October 1998), pp. 583-592. by S. M. Haffner posted by 5 people HEIRS - Environmental Illness Research HEIRS Diabetes, Insulin Resistance and Metabolic Syndrome Research HEIRS Cardiology HEIRS nm61591
	Fasting blood glucose: an underestimated risk factor for cardiovascular death. Results from a 22-year follow-up of healthy nondiabetic men. [My Copy] Diabetes care, Vol. 22, No. 1. (January 1999), pp. 45-49. by J. V. Bjørnholt, G. Erikssen, E. Aaser, et al.L. Sandvik, S. Nitter-Hauge, J. Jervell, J. Erikssen, E. Thaulow posted by 1 person nm61591
	Discussion [My Copy] Neuroscience, Vol. 86, No. 2. (01 June 1998), pp. 353-387. posted by 1 person chouhan
	Dopamine Dependency of Oscillations between Subthalamic Nucleus and Pallidum in Parkinson's Disease [My Copy] J. Neurosci., Vol. 21, No. 3. (1 February 2001), pp. 1033-1038. by Peter Brown, Antonio Oliviero, Paolo Mazzone, Angelo Insola, Pietro Tonali, Vincenzo Di Lazzaro posted by 1 person chouhan
	Selective Innervation of Neostriatal Interneurons by a Subclass of Neuron in the Globus Pallidus of the Rat [My Copy] J. Neurosci., Vol. 18, No. 22. (15 November 1998), pp. 9438-9452. by Mark D. Bevan, Philip A. C. Booth, Sean A. Eaton, J. Paul Bolam posted by 1 person chouhan
	The extreme male brain theory of autism [My Copy] Trends in Cognitive Sciences, Vol. 6, No. 6. (1 June 2002), pp. 248-254. by S. Baron-Cohen posted by 1 person chouhan
	Synaptic vesicle biogenesis, docking, and fusion: a molecular description [My Copy] Physiol. Rev., Vol. 76, No. 1. (1 January 1996), pp. 1-29. by N. Calakos, R. H. Scheller posted by 1 person chouhan
	Expectation and Dopamine Release: Mechanism of the Placebo Effect in Parkinson's Disease [My Copy] Science, Vol. 293, No. 5532. (10 August 2001), pp. 1164-1166. by Raul de la Fuente-Fernandez, Thomas J. Ruth, Vesna Sossi, Michael Schulzer, Donald B. Calne, A. Jon Stoessl posted by 1 person chouhan
	Objective changes in motor function during placebo treatment in PD [My Copy] Neurology, Vol. 54, No. 3. (8 February 2000), 710. by Christopher G. Goetz, Sue Leurgans, Rema Raman, Glenn T. Stebbins posted by 1 person chouhan
	Conscious Expectation and Unconscious Conditioning in Analgesic, Motor, and Hormonal Placebo/Nocebo Responses [My Copy] J. Neurosci., Vol. 23, No. 10. (15 May 2003), pp. 4315-4323. by Fabrizio Benedetti, Antonella Pollo, Leonardo Lopiano, Michele Lanotte, Sergio Vighetti, Innocenzo Rainero posted by 1 person chouhan
	Behavioral conditioning of immunosuppression is possible in humans [My Copy] FASEB J., Vol. 16, No. 14. (1 December 2002), pp. 1869-1873. by Marion U. Goebel, Almuth E. Trebst, J. A. N. Steiner, et al.Yu F. Xie, Michael S. Exton, Stilla Frede, Ali E. Canbay, Martin C. Michel, U. W. E. Heemann, Manfred Schedlowski posted by 1 person chouhan
	Descending analgesia – When the spine echoes what the brain expects [My Copy] Pain, Vol. 130, No. 1-2. (July 2007), pp. 137-143. by P. Goffaux, W. Redmond, P. Rainville, S. Marchand posted by 1 person chouhan
	Imaging cognitive modulation of pain processing [My Copy] Pain, Vol. 95, No. 1-2. (January 2002), pp. 1-5. by P. Petrovic posted by 1 person chouhan
	Placebo effects on human Î¼-opioid activity during pain [My Copy] Proceedings of the National Academy of Sciences, Vol. 104, No. 26. (26 June 2007), pp. 11056-11061. by Tor D. Wager, David J. Scott, Jon-Kar Zubieta posted by 1 person chouhan
	Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients [My Copy] Pain, Vol. 127, No. 1-2. (January 2007), pp. 63-72. by D. Price, J. Craggs, G. Nicholasverne, W. Perlstein, M. Robinson posted by 1 person chouhan
	The neural correlates of placebo effects: a disruption account [My Copy] NeuroImage, Vol. 22, No. 1. (May 2004), pp. 447-455. by M. Lieberman posted by 1 person chouhan
	Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network [My Copy] Pain, Vol. 120, No. 1-2. (January 2006), pp. 8-15. by U. Bingel, J. Lorenz, E. Schoell, C. Weiller, C. Buchel posted by 1 person chouhan
	Response variability to analgesics: a role for non-specific activation of endogenous opioids [My Copy] Pain, Vol. 90, No. 3. (15 February 2001), pp. 205-215. by M. Amanzio posted by 1 person chouhan
	The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia [My Copy] Pain, Vol. 64, No. 3. (March 1996), pp. 535-543. by F. Benedetti posted by 1 person chouhan
	How prior experience shapes placebo analgesia [My Copy] Pain, Vol. 124, No. 1-2. (September 2006), pp. 126-133. by Luana Colloca, Fabrizio Benedetti posted by 1 person chouhan
	Response expectancies in placebo analgesia and their clinical relevance [My Copy] Pain, Vol. 93, No. 1. (July 2001), pp. 77-84. by A. Pollo posted by 1 person chouhan
	A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia [My Copy] Pain, Vol. 99, No. 3. (October 2002), pp. 443-452. by L. Vase, J. Rileyiii, D. Price posted by 1 person chouhan
	Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment [My Copy] Journal of Internal Medicine, Vol. 256, No. 2. (2004), pp. 91-100. by A. Hróbjartsson, P. C. Gøtzsche posted by 1 person chouhan
	Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity [My Copy] The Journal of Pain, Vol. 10, No. 9. (September 2009), pp. 895-926. by Alban Latremoliere, Clifford J. Woolf posted by 1 person chouhan
	Pain mechanisms: a new theory. [My Copy] Science (New York, N.Y.), Vol. 150, No. 699. (19 November 1965), pp. 971-979. by R. Melzack, P. D. Wall posted by 1 person chouhan
	Descending control of pain [My Copy] Progress in Neurobiology, Vol. 66, No. 6. (April 2002), pp. 355-474. by M. Millan posted by 1 person chouhan
	Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry [My Copy] Annual Review of Neuroscience, Vol. 7, No. 1. (1984), pp. 309-338. by A. I. Basbaum, H. L. Fields posted by 1 person chouhan
	Powerful placebo: the dark side of the randomised controlled trial [My Copy] The Lancet, Vol. 351, No. 9117. (06 June 1998), pp. 1722-1725. by T. Kaptchuk posted by 1 person chouhan
	THE PLACEBO EFFECT IN THE HISTORY OF MEDICAL TREATMENT IMPLICATIONS FOR PSYCHIATRY [My Copy] Am J Psychiatry, Vol. 116, No. 4. (1 October 1959), pp. 298-304. by Arthur K. Shapiro posted by 1 person chouhan
	The need for a new medical model: a challenge for biomedicine [My Copy] Science, Vol. 196, No. 4286. (8 April 1977), pp. 129-136. by G. L. Engel posted by 2 people chouhan thefader
	Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson's disease [My Copy] Experimental Neurology, Vol. 188, No. 2. (August 2004), pp. 480-490. by Peter Brown,, Paolo Mazzone,, Antonio Oliviero,, et al.Maria r. a. z. i. a. Altibrandi,, Fabio Pilato,, Pietro .. Tonali,, Lazzaro, i. n. c. e. n. z. o. Di posted by 2 people chouhan joundi99
	Event-related beta desynchronization in human subthalamic nucleus correlates with motor performance [My Copy] Brain, Vol. 127, No. 4. (1 April 2004), pp. 735-746. by Andrea A. Kuhn, David Williams, Andreas Kupsch, et al.Patricia Limousin, Marwan Hariz, Gerd-Helge Schneider, Kielan Yarrow, Peter Brown posted by 3 people chouhan joundi99 Whyking
	Functional significance of the cortico–subthalamo–pallidal 'hyperdirect' pathway [My Copy] Neuroscience Research, Vol. 43, No. 2. (June 2002), pp. 111-117. by A Nambu, posted by 2 people chouhan Whyking
	Electrical Coupling and Neuronal Synchronization in the Mammalian Brain [My Copy] Neuron, Vol. 41, No. 4. (19 February 2004), pp. 495-511. by Michael V. L. Bennett, Zukin posted by 2 people chouhan rnaylor
	In search of lost presynaptic inhibition [My Copy] Experimental Brain Research, Vol. 196, No. 1. (1 June 2009), pp. 139-151. by Pablo Rudomin posted by 1 person chouhan
	A Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought [My Copy] Annual Review of Psychology, Vol. 59, No. 1. (2008), pp. 565-590. by Donald D. Price, Damien G. Finniss, Fabrizio Benedetti posted by 2 people chouhan sfcheung